Contrasting Cholesterol Management Guidelines for Adults with CKD

Area of Science:

• Nephrology
• Cardiology
• Epidemiology

Background:

• The Kidney Disease Improving Global Outcomes (KDIGO) and American College of Cardiology/American Heart Association (ACC/AHA) provide differing statin recommendations for adults.
• Chronic kidney disease (CKD) is a significant risk factor for cardiovascular disease (CVD).

Purpose of the Study:

• To compare statin treatment recommendations between KDIGO and ACC/AHA guidelines for adults aged 50-79 with CKD.
• To assess the validity of the ACC/AHA Pooled Cohort risk equations in predicting CVD events in the CKD population.

Main Methods:

• Utilized data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
• Calculated agreement for statin initiation between KDIGO and ACC/AHA guidelines in 4726 adults with CKD not on dialysis.
• Assessed CVD event incidence and the calibration/discrimination of Pooled Cohort risk equations.

Main Results:

• 50% of CKD participants were on statins, while 42% met ACC/AHA criteria but were not treated.
• Only 8% of participants did not meet ACC/AHA criteria for statin initiation.
• The Pooled Cohort risk equations demonstrated good calibration and moderate discrimination in the CKD cohort.

Conclusions:

• The KDIGO and ACC/AHA guidelines exhibit high concordance for statin treatment recommendations in adults with CKD.
• The findings support the use of these guidelines for statin therapy decisions in CKD patients.
• The Pooled Cohort risk equations are a valid tool for CVD risk assessment in individuals with CKD.